Search Results 131-140 of 580 for ✉대회 애틀란타커뮤니티 송금✉
TP-0903 is a novel oral inhibitor that targets AXL kinase. Preclinical studies have shown promising antitumor activity of TP-0903 as a single agent against a ...
As a trainee, your physical and mental health is a priority to both Mayo Clinic and the Department of Cardiovascular Medicine. Trainees have access to several ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The goal of this study is to evaluate a new approach to immunotherapy in NHL by combining two antibodies, veltuzumab and epratuzumab. For treatment, epratuzumab ...
About this study. The purpose of this dose-escalation study is to evaluate the safety, tolerability, pharmacokinetics (PK) and effectiveness of venetoclax, ...
The investigators identify women age 40 and younger with newly-diagnosed breast cancer from academic and community healthcare institutions. After women ...
Eligibility and application process details for the Echocardiography Program at Mayo Clinic in Phoenix/Scottsdale, Arizona, and Rochester, Minnesota.
The purpose of this study is to test any good and bad effects of adding the drug Blinatumomab to different doses of standard combination of chemotherapy drugs.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.